MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-21 and Dicer are dispensable for hepatic stellate cell activation and the development of liver fibrosis
Authors
Keywords
-
Journal
HEPATOLOGY
Volume 67, Issue 6, Pages 2414-2429
Publisher
Wiley
Online
2017-11-02
DOI
10.1002/hep.29627
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice
- (2017) Shanshan Zhang et al. JOURNAL OF HEPATOLOGY
- Absence of microRNA-21 does not reduce muscular dystrophy in mouse models of LAMA2-CMD
- (2017) Bernardo Moreira Soares Oliveira et al. PLoS One
- Epithelial Transforming Growth Factor-β Signaling Does Not Contribute to Liver Fibrosis but Protects Mice From Cholangiocarcinoma
- (2016) Xueru Mu et al. GASTROENTEROLOGY
- Knockout of microRNA-21 reduces biliary hyperplasia and liver fibrosis in cholestatic bile duct ligated mice
- (2016) Lindsey L Kennedy et al. LABORATORY INVESTIGATION
- Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches
- (2016) Julia Beermann et al. PHYSIOLOGICAL REVIEWS
- miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells
- (2015) J. Zhang et al. CANCER RESEARCH
- High-yield and high-purity isolation of hepatic stellate cells from normal and fibrotic mouse livers
- (2015) Ingmar Mederacke et al. Nature Protocols
- Towards a molecular understanding of microRNA-mediated gene silencing
- (2015) Stefanie Jonas et al. NATURE REVIEWS GENETICS
- Origin and Function of Myofibroblasts in the Liver
- (2015) Robert Schwabe et al. SEMINARS IN LIVER DISEASE
- Integrative miRNA and Gene Expression Profiling Analysis of Human Quiescent Hepatic Stellate Cells
- (2015) Mar Coll et al. Scientific Reports
- The role of miRNAs in stress-responsive hepatic stellate cells during liver fibrosis
- (2015) Joeri Lambrecht et al. Frontiers in Physiology
- Aberrant Regulation and Function of MicroRNAs in Cancer
- (2014) Brian D. Adams et al. CURRENT BIOLOGY
- Cell Death and Cell Death Responses in Liver Disease: Mechanisms and Clinical Relevance
- (2014) Tom Luedde et al. GASTROENTEROLOGY
- MicroRNA-21 in Glomerular Injury
- (2014) J. Y. Lai et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Hepatic macrophages but not dendritic cells contribute to liver fibrosis by promoting the survival of activated hepatic stellate cells in mice
- (2013) Jean-Philippe Pradere et al. HEPATOLOGY
- The Autoregulatory Feedback Loop of MicroRNA-21/Programmed Cell Death Protein 4/Activation Protein-1 (MiR-21/PDCD4/AP-1) as a Driving Force for Hepatic Fibrosis Development
- (2013) Zhengping Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- MicroRNAs in liver disease
- (2013) Gyongyi Szabo et al. Nature Reviews Gastroenterology & Hepatology
- Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology
- (2013) Ingmar Mederacke et al. Nature Communications
- Promotion of Hepatocellular Carcinoma by the Intestinal Microbiota and TLR4
- (2012) Dianne H. Dapito et al. CANCER CELL
- MicroRNAs in Stress Signaling and Human Disease
- (2012) Joshua T. Mendell et al. CELL
- Roles for MicroRNAs in Conferring Robustness to Biological Processes
- (2012) Margaret S. Ebert et al. CELL
- MicroRNAs in Liver Disease
- (2012) Xin Wei Wang et al. GASTROENTEROLOGY
- A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration
- (2012) Raymond Ng et al. JOURNAL OF CLINICAL INVESTIGATION
- Disease-linked microRNA-21 exhibits drastically reduced mRNA binding and silencing activity in healthy mouse liver
- (2012) J. R. Androsavich et al. RNA
- MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways
- (2012) B. N. Chau et al. Science Translational Medicine
- Pathogenesis of Liver Fibrosis
- (2011) Virginia Hernandez-Gea et al. Annual Review of Pathology-Mechanisms of Disease
- Comparison of different miR-21 inhibitor chemistries in a cardiac disease model
- (2011) Thomas Thum et al. JOURNAL OF CLINICAL INVESTIGATION
- Response to Thum et al.
- (2011) David M. Patrick et al. JOURNAL OF CLINICAL INVESTIGATION
- Loss of the miR-21 allele elevates the expression of its target genes and reduces tumorigenesis
- (2011) X. Ma et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Modulation of K-Ras-Dependent Lung Tumorigenesis by MicroRNA-21
- (2010) Mark E. Hatley et al. CANCER CELL
- Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis
- (2010) Christoph Roderburg et al. HEPATOLOGY
- Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice
- (2010) David M. Patrick et al. JOURNAL OF CLINICAL INVESTIGATION
- miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis
- (2010) Gang Liu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma
- (2010) Pedro P. Medina et al. NATURE
- Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies
- (2010) Inge A M de Graaf et al. Nature Protocols
- MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3
- (2009) Florin M. Selaru et al. HEPATOLOGY
- Biogenesis of small RNAs in animals
- (2009) V. Narry Kim et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations
- (2008) Yannick Ladeiro et al. HEPATOLOGY
- MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
- (2008) Thomas Thum et al. NATURE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started